Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: European Pharmacopoeia monograph requirements | Statement: [CEP, basisOfAssessment, European Pharmacopoeia monograph requirements]

Target entity: European Pharmacopoeia monograph requirements
Context triple: [CEP, basisOfAssessment, European Pharmacopoeia monograph requirements]

• A. European Pharmacopoeia chosen
  The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
• B. Certificates of Suitability to the monographs of the European Pharmacopoeia
  Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
• C. European Union pharmaceutical legislation
  European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
• D. ICH Q3A Impurities in New Drug Substances
  ICH Q3A Impurities in New Drug Substances is an international regulatory guideline that sets quality standards and thresholds for identifying, reporting, and controlling impurities in new active pharmaceutical ingredients.
• E. ICH Q11 Development and Manufacture of Drug Substances
  ICH Q11 Development and Manufacture of Drug Substances is an ICH guideline that provides principles and expectations for the development and manufacturing of chemical and biotechnological drug substances within a quality-by-design framework.
• F. None of above.
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target predicate: basisOfAssessment
Context triple: [CEP, basisOfAssessment, European Pharmacopoeia monograph requirements]

• A. assessmentBasis
  Indicates the underlying criteria, evidence, or method used as the foundation for making an assessment or evaluation between entities.
• B. evaluationBasis chosen
  Indicates the criteria, standards, or reference framework used to judge, assess, or measure something in an evaluation process.
• C. assessedBy
  Indicates that an entity has been evaluated, examined, or judged by another entity (typically an agent or authority).
• D. basedOnAspect
  Indicates that one entity is derived, determined, or defined according to a particular aspect, feature, or dimension of another entity.
• E. typeOfAssessmentInfluenced
  Indicates that one entity has an effect on or shapes the kind of assessment applied to another entity.
• F. None of above.